Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Lipoxin pathway is a complex biochemical pathway involved in the resolution of inflammation. It is mediated by bioactive lipids, particularly lipoxin A4 and B4, which are derived from arachidonic acid. These lipoxins act on specific receptors like FPR2/ALX to inhibit leukocyte recruitment, promote phagocytosis of apoptotic cells, and reduce inflammation, thereby contributing to tissue homeostasis and repair. They are considered potential therapeutic targets for treating chronic inflammatory disorders.
Inhibition of pro-inflammatory signaling pathways (e.g., NF-κB, PI3K/Akt); Promotion of anti-inflammatory signaling pathways (e.g., NRF2); Stimulation of macrophage phagocytosis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoxin pathway (LX pathway).